
Hy-Tech Engineers, Symbiotec Pharmalab and Skyways Air Services opened their IPOs together, with investors comparing grey market premiums, implied listing gains, issue sizes and lot returns. The combined fund-raising target is above…
Hy-Tech Engineers, Symbiotec Pharmalab and Skyways Air Services opened their IPOs together, with investors comparing grey market premiums, implied listing gains, issue sizes and lot returns. The combined fund-raising target is above Rs 2,475 crore, according to NDTV Profit.
NDTV Profit separately reported that Skyways Air Services opened on August 24 with a Rs 583 crore issue. It cited a 23% GMP premium and 32% profit-after-tax growth for the company. In another comparison, the publication said Hy-Tech Engineers led with a 56% GMP gain, followed by Symbiotec Pharmalab and Skyways Air. GMP figures can change before listing, while allotment details remain relevant to investors.
The three reports use the same market indicator but give it different prominence. The first frames the story as a comparison of potential listing gains and investor returns, while the second combines Skyways’ GMP with its operating growth. The third leads with the strongest reported GMP, making Hy-Tech appear the clearest listing-gain candidate. These figures are expectations in the grey market, not guaranteed listing prices, and the reports provide limited detail on valuation or subscription demand. The stated issue sizes and final allotment details are the next concrete points for investors to assess.
Coverage: 3 sources, 3 neutral
Sources (3): ndtvprofit.com (neutral report), ndtvprofit.com (2) (neutral report), ndtvprofit.com (3) (neutral report)
This story was synthesised by AI from the 3 sources linked above.
Updated: this story now draws on 3 sources.